C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Relapsed Neuroblastoma|Refractory Neuroblastoma|Relapsed Osteosarcoma|Relapsed Ewing Sarcoma|Relapsed Rhabdomyosarcoma|Uveal Melanoma|Phyllodes Breast Tumor
Interventions: GENETIC: C7R-GD2.CART cells
Sponsor: Baylor College of Medicine
Collaborators: Center for Cell and Gene Therapy, Baylor College of Medicine|The Methodist Hospital Research Institute|Cancer Prevention Research Institute of Texas